Health News Releases

May 14, 09:55

AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Disease

Takeda (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.takeda.com%2F&esheet=53983823&newsitemid=20240510475155&lan=en-US&anchor=Takeda&index=1&md5=4a403ee030780c54b5ebde46e786f5

May 13, 10:20

Takeda Announces FY2023 Full Year Results and FY2024 Outlook, Affirming Commitment to Late-Stage Pipeline Development and Core Operating Profit Margin Expansion

Takeda (TOKYO:4502/NYSE:TAK) today announced financial results for fiscal year 2023 (period ended March 31, 2024), delivering its Management Guidance for Core Operating Profit and exceeding its Manage

May 10, 14:55

BeiGene Reports First Quarter 2024 Financial Results and Business Updates

BeiGene (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.beigene.com%2F&esheet=53978747&newsitemid=20240508878785&lan=en-US&anchor=BeiGene&index=1&md5=289a1210b11d33d3f6dbd570f8e

May 09, 15:40

LC-Plasma-based Vaccine Research Selected for SCARDA Project

Kirin Holdings Company, Limited (Kirin Holdings)(TOKYO:2503) and National Institute of Infectious Diseases (NIID) are jointly conducting studies to investigate the protective efficacy of L. lactis str

May 09, 13:55

Study Suggests Critical Link Between Residual FLT3-ITD Mutations in Remission and Post-Transplant Outcomes in AML

A groundbreaking research study,[1] sequencing DNA samples from the Pre-MEASURE study[2] strongly indicates that the detection of residual FLT3 internal tandem duplication (ITD) mutations in the blood

May 07, 14:35

Galderma Receives Filing Acceptances for Nemolizumab in Prurigo Nodularis and Atopic Dermatitis in Four Additional Countries

Galderma today announced that it has received filing acceptances for nemolizumab for the treatment of patients with prurigo nodularis and for adolescents and adults with moderate-to-severe atopic derm

May 07, 11:30

Parse Biosciences Launches Single Cell Immune Profiling Products

Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced the availability of Evercode™ BCR and the expansion of its existing Evercode™ TCR pro

May 03, 10:35

Mariana Oncology to be Acquired by Novartis to Advance Precision Radiopharmaceuticals to Treat Cancer

Mariana Oncology, a fully integrated biotechnology company pioneering a new era of radiopharmaceutical innovation to treat people with cancer, today announced it will be acquired by Novartis for $1 bi

May 01, 12:55

WHOOP Announces Significant Global Expansion, Appoints New Senior Leadership

WHOOP (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.whoop.com%2F&esheet=53961244&newsitemid=20240429085870&lan=en-US&anchor=WHOOP&index=1&md5=208ea6634cca605d44e019265ce45daf)

April 28, 13:10

Takeda Receives Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer

Takeda (TSE:4502/NYSE:TAK (https://www.takeda.com/investors/overview/)) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has recommended

April 28, 11:40

CORRECTING and REPLACING ReNAgade Therapeutics Continues Commitment to GanNA Bio and Glycan Biology

Please replace the release dated April 26, 2024 with the following corrected version due to multiple revisions. The updated release reads: RENAGADE THERAPEUTICS CONTINUES COMMITMENT TO GANNA BIO

April 25, 17:05

Exergen Sues Baxter International to Defend Its Right to Publish Data Regarding the Accuracy of Oral Thermometers

Last week Exergen Corporation filed a lawsuit against Baxter International Inc. in the United States District Court for the District of Massachusetts. As detailed in its complaint, Exergen’s lawsuit i

April 25, 14:55

Parse Biosciences Launches Laboratory Automation Provider Program, Collaborates with Hamilton, Opentrons Labworks, SPT Labtech

Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced it has launched its Laboratory Automation Provider Program, enabling automation provi

April 24, 14:34

Galderma Delivers a Strong Start to the Year With Record Net Sales of Over 1 Billion USD for the First Quarter and 12.4% Year-on-Year Growth

Galderma Group AG (SWX:GALD), the pure-play dermatology category leader, today announced its sales performance for the first quarter of 2024. · Record net sales of 1.071 billion USD in the first qu

April 24, 10:10

Rubedo Life Sciences and Beiersdorf Announce Multi-Year Partnership to Pioneer New Skin Care Products that Address Cellular Aging

Rubedo Life Sciences (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.rubedolife.com%2F&esheet=53939040&newsitemid=20240423657886&lan=en-US&anchor=Rubedo+Life+Sciences&index=1&md

April 24, 09:30

ReNAgade Therapeutics Announces Presentations at the ASGCT 27th Annual Meeting

ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced an oral and poster presentation highlighting preclinical data supporting its comprehensive RNA tec

April 23, 16:50

AI Medical Service Inc. Signs Joint Research Agreement with Mahidol University in Thailand

AI MEDICAL SERVICE INC. (hereinafter AIM), a medical start-up specializing in the development of diagnostic endoscopic AI, signed a joint research agreement with Mahidol University in Thailand (herein

April 23, 15:45

Toyoda Gosei Develops UV-C LED with World-Class Light Output

Toyoda Gosei Co., Ltd. (TOKYO:7282) has developed deep ultraviolet (UV-C) LEDs with light output that is among the highest in the world.[1] UV-C is used in disinfection as it destroys viral and bacter

April 23, 09:45

Rubedo Life Sciences Closes $40M Series A Financing Led by Khosla Ventures and Ahren Innovation Capital

Rubedo Life Sciences (https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.rubedolife.com%2F&esheet=53939039&newsitemid=20240422384739&lan=en-US&anchor=Rubedo+Life+Sciences&index=1&md

April 18, 15:40

The Office of Health Economics: Adult Vaccination Programmes Deliver Socio-economic Benefits up to 19 Times Initial Investment, According to New Report

A new report published today reveals that adult vaccination programmes can return up to 19 times their initial investment when the full spectrum of economic and societal benefits is valued. The 19x re

April 18, 14:15

Masimo Founder and CEO Joe Kiani to Speak on AI at Global Patient Safety Summit in Chile

Masimo (https://www.masimo.com/en-us/) (NASDAQ: MASI) today announced that its Founder and CEO, Joe Kiani, will be a featured speaker tomorrow, April 17, at the 6th Global Ministerial Summit on Patien

April 18, 08:00

INB Korea Ltd removes the bubble of the price on air sterilizer, cutting the price by 70% , NEW ‘UPPERVIOLET ODEO’ product is launched

INB Korea Ltd, the manufacturer of ‘viruskiller’, a K- air purifier and sterilizer product in Korea that exported 20 million dollar to 53 countries during the COVID19 outbreak, announced on the 17th o

April 17, 09:57

A new chapter for Medisca: Sanjay D. Goorachurn appointed as Chief Executive Officer

Medisca, a global company specializing in personalized pharmaceutical solutions, is pleased to announce the appointment of Sanjay D. Goorachurn as the company’s new CEO, as founders, Tony Dos Santos a

April 17, 09:15

MRM Health Reports Safety and Positive Efficacy Data in Pouchitis in Phase 2a Clinical Study with MH002

MRM Health NV, a clinical-stage biopharmaceutical company developing innovative therapeutics for inflammatory, CNS and metabolic diseases, today reports positive topline results from its Phase 2a clin

April 16, 11:40

KBI Biopharma Appoints Jean-Baptiste Agnus as Chief Business Officer

KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and global cGMP contract development and manufacturing organization (CDMO), today announced the appointment of Jean-Baptiste (JB) Agnus as Chief

News by Region

News by Industry